Hello I'm Raiyyan Tahsan
Brand Model and Executive

TC(1349).(19).Gastroenterology Case No 53. Suspected IBS-C/CIC + Probable BPH with LUTS + Anxiety Symptoms + Bilateral LL Paraesthesia (under evaluation). (Prescription 1)5577

Prescription attached:-

đŸŠē Prescription Review, Drug Analysis & Clinical Working Diagnosis

Based on Harrison’s Principles of Internal Medicine, Davidson’s Medicine, EAU Guidelines, ACG Guidelines and MedEx Bangladesh

Author: Md.Rafiqul Islam Lipu

Date: Tuesday, 13 October 2026

Time: 6:02 PM (Bangladesh Time)

Prescription Information

  • Prescribing Physician: Dr. Md. Robed Amin, MBBS, FCPS (Medicine)
  • Specialty: Medicine Specialist
  • Patient: Male
  • Age: Approximately 70 years at the time of consultation
  • Prescription Date: 23 February 2020

Clinical interpretation notice: āĻāϟāĻŋ ⧍ā§Ļ⧍ā§Ļ āϏāĻžāϞ⧇āϰ āĻāĻ•āϟāĻŋ āĻĒ⧁āϰ⧋āύ⧋ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύāĨ¤ āĻšāĻžāϤ⧇āϰ āϞ⧇āĻ–āĻž āĻāĻŦāĻ‚ āĻ›āĻŦāĻŋāϰ āĻŦāĻžāĻŽ āĻĒāĻžāĻļ⧇āϰ āĻ•āĻŋāϛ⧁ āĻ…āĻ‚āĻļ āĻ…āĻ¸ā§āĻĒāĻˇā§āϟāĨ¤ āϤāĻžāχ āϝ⧇āϏāĻŦ āϤāĻĨā§āϝ āĻ¸ā§āĻĒāĻˇā§āϟ, āϏ⧇āϗ⧁āϞ⧋ āφāϞāĻžāĻĻāĻž āĻ•āϰ⧇āĻ›āĻŋ āĻāĻŦāĻ‚ āĻ…āύāĻŋāĻļā§āϚāĻŋāϤ āĻ…āĻ‚āĻļ⧇ āϤāĻž āωāĻ˛ā§āϞ⧇āĻ– āĻ•āϰ⧇āĻ›āĻŋāĨ¤ āύāĻŋāĻšā§‡āϰ diagnosis āĻāĻ•āϟāĻŋ retrospective clinical assessment, āĻŦāĻ°ā§āϤāĻŽāĻžāύ āϰ⧋āĻ—ā§€āϰ āύāĻŋāĻļā§āϚāĻŋāϤ diagnosis āύ⧟āĨ¤

1. Prescription Marking — C/C, O/E, Advice, Investigation & Dx

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻ…āĻ‚āĻļāϗ⧁āϞ⧋ āφāϞāĻžāĻĻāĻž āϰāϙ⧇āϰ āĻŦāĻ•ā§āϏ āĻĻāĻŋā§Ÿā§‡ āϚāĻŋāĻšā§āύāĻŋāϤ āĻ•āϰ⧇āĻ›āĻŋāĨ¤

Share

đŸ“Ĩ Download Marked Prescription

Marked colour Clinical section
🔴 Red Chief complaints and history
đŸ”ĩ Blue On examination
đŸŸĸ Green Doctor's diagnosis
đŸŸŖ Purple Advice and investigations
🟠 Orange Prescribed medicines

2. C/C — Chief Complaints (āĻĒā§āϰāϧāĻžāύ āωāĻĒāϏāĻ°ā§āĻ—)

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻŦāĻžāĻŽ āĻĒāĻžāĻļ⧇ āύāĻŋāĻšā§‡āϰ āϤāĻĨā§āϝāϗ⧁āϞ⧋ āĻĒ⧜āĻž āϝāĻžāĻšā§āϛ⧇āĨ¤

Clinical term āĻŦāĻžāĻ‚āϞāĻž āĻ…āĻ°ā§āĻĨ Reading confidence
Bowel disturbance āĻŽāϞāĻ¤ā§āϝāĻžāϗ⧇āϰ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻ…āĻ­ā§āϝāĻžāϏ⧇ āϏāĻŽāĻ¸ā§āϝāĻž Moderate
Insomnia āĻ…āύāĻŋāĻĻā§āϰāĻž āĻŦāĻž āϘ⧁āĻŽā§‡āϰ āϏāĻŽāĻ¸ā§āϝāĻž High
Paraesthesia of both lower limbs āωāϭ⧟ āĻĒāĻžā§Ÿā§‡ āĻāĻŋāύāĻāĻŋāύ āĻŦāĻž āĻ…āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻ…āύ⧁āĻ­ā§‚āϤāĻŋ High
Palpitation — probable āĻŦ⧁āĻ• āϧ⧜āĻĢ⧜ āĻ•āϰāĻž Low–moderate
Shivering sensation — probable āĻļāϰ⧀āϰ⧇ āĻ•āĻžāρāĻĒ⧁āύāĻŋ āĻ…āύ⧁āĻ­āĻŦ āĻ•āϰāĻž Moderate
Urinary urgency āĻšāĻ āĻžā§Ž āϤ⧀āĻŦā§āϰ āĻĒā§āϰāĻ¸ā§āϰāĻžāĻŦ⧇āϰ āĻŦ⧇āĻ— Moderate
Burning during urination āĻĒā§āϰāĻ¸ā§āϰāĻžāĻŦ⧇āϰ āϏāĻŽā§Ÿ āĻœā§āĻŦāĻžāϞāĻžāĻĒā§‹ā§œāĻž Moderate

āĻĒā§āϰāĻĨāĻŽ āϞāĻžāχāύ⧇āϰ āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āĻŦāĻ•ā§āϤāĻŦā§āϝ āĻāĻŦāĻ‚ āĻ•ā§Ÿā§‡āĻ•āϟāĻŋ āĻļāĻŦā§āĻĻ āĻ…āĻ¸ā§āĻĒāĻˇā§āϟāĨ¤ IBS-C diagnosis āĻĨ⧇āϕ⧇ constipation-āĻāϰ āϧāĻžāϰāĻŖāĻž āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§Ÿ, āϤāĻŦ⧇ āĻŽā§‚āϞ C/C-āϤ⧇ āĻŽāϞāĻ¤ā§āϝāĻžāϗ⧇āϰ āĻŦāĻŋāĻ¸ā§āϤāĻžāϰāĻŋāϤ āĻŦāĻŋāĻŦāϰāĻŖ āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ āύ⧟āĨ¤

āωāĻ˛ā§āϞ⧇āĻ–āĻŋāϤ Patient History

HTN āϞ⧇āĻ–āĻž āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻ…āĻ°ā§āĻĨāĻžā§Ž āϰ⧋āĻ—ā§€āϰ āĻĒā§‚āĻ°ā§āĻŦ āĻĨ⧇āϕ⧇ āωāĻšā§āϚ āϰāĻ•ā§āϤāϚāĻžāĻĒ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ āĻĨāĻžāĻ•āĻžāϰ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻž āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āϤāĻŦ⧇ āĻāϟāĻŋ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇ āφāϗ⧇āϰ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ āĻŦāĻž āϰ⧋āĻ—ā§€āϰ medication history āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤


3. O/E — On Examination (āĻļāĻžāϰ⧀āϰāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻž)

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰāĻ­āĻžāĻŦ⧇ āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžāĻšā§āϛ⧇:

Blood Pressure: 120/90 mmHg

Clinical interpretation:

  • Systolic BP: 120 mmHg
  • Diastolic BP: 90 mmHg

āĻāϟāĻŋ āĻāĻ•āĻŦāĻžāϰ⧇āϰ āϰāĻ•ā§āϤāϚāĻžāĻĒ⧇āϰ āĻĒāϰāĻŋāĻŽāĻžāĻĒāĨ¤ āĻļ⧁āϧ⧁ āĻāχ reading āĻĻāĻŋā§Ÿā§‡ hypertension-āĻāϰ āĻŦāĻ°ā§āϤāĻŽāĻžāύ āύāĻŋ⧟āĻ¨ā§āĻ¤ā§āϰāĻŖ āĻŦāĻž diagnosis āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤

āĻ…āĻ¨ā§āϝ examination findings-āĻāϰ āĻŽāĻ§ā§āϝ⧇ āĻ•ā§Ÿā§‡āĻ•āϟāĻŋ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• finding āϞ⧇āĻ–āĻž āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻŦ⧇ āĻļāĻŦā§āĻĻāϗ⧁āϞ⧋ āĻ¸ā§āĻĒāĻˇā§āϟ āύ⧟ āĻŦāϞ⧇ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ organ-system examination āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻ›āĻŋāϞ āĻŦāϞ⧇ āĻĻāĻžāĻŦāĻŋ āĻ•āϰāĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤

Important: Prostate-āĻāϰ DRE finding āĻŦāĻž ultrasound prostate volume āĻāĻ–āĻžāύ⧇ āĻ¸ā§āĻĒāĻˇā§āϟāĻ­āĻžāĻŦ⧇ āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋāĨ¤


4. Doctor's Diagnosis — Prescribing Physician's Dx

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āύāĻŋāĻšā§‡āϰ āĻŦāĻžāĻŽ āĻ…āĻ‚āĻļ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āϏāĻŽā§āĻ­āĻŦāϤ āϤāĻŋāύāϟāĻŋ diagnosis āϞāĻŋāϖ⧇āϛ⧇āύāĨ¤

No. Doctor's Dx āĻŦāĻžāĻ‚āϞāĻž Clinical Meaning Confidence
1 IBS-C āϕ⧋āĻˇā§āĻ āĻ•āĻžāĻ āĻŋāĻ¨ā§āϝ-āĻĒā§āϰāϧāĻžāύ āχāϰāĻŋāĻŸā§‡āĻŦāϞ āĻŦāĻžāĻ“ā§Ÿā§‡āϞ āϏāĻŋāĻ¨ā§āĻĄā§āϰ⧋āĻŽ 0.85
2 Enlarged Prostate āĻĒā§āϰ⧋āĻ¸ā§āĻŸā§‡āϟ āĻ—ā§āϰāĻ¨ā§āĻĨāĻŋāϰ āφāĻ•āĻžāϰ āĻŦ⧃āĻĻā§āϧāĻŋ 0.95
3 Anxiety Disorder āωāĻĻā§āĻŦ⧇āĻ—āϜāύāĻŋāϤ āĻŽāĻžāύāϏāĻŋāĻ• āĻŦā§āϝāĻžāϧāĻŋ 0.90

Diagnosis 1: Irritable Bowel Syndrome with Constipation (IBS-C)

āĻāϟāĻŋ āĻ…āĻ¨ā§āĻ¤ā§āϰ⧇āϰ āĻ•āĻžāĻ°ā§āϝāĻ•ā§āϰāĻŽā§‡āϰ āĻāĻ•āϟāĻŋ disorder, āϝ⧇āĻ–āĻžāύ⧇ āĻŦāĻžāϰāĻŦāĻžāϰ āĻĒ⧇āϟāĻŦā§āϝāĻĨāĻžāϰ āϏāĻ™ā§āϗ⧇ āĻŽāϞāĻ¤ā§āϝāĻžāϗ⧇āϰ āϧāϰāύ āĻ“ āϘāύāĻ¤ā§āĻŦ⧇āϰ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ āϘāĻŸā§‡ āĻāĻŦāĻ‚ āϕ⧋āĻˇā§āĻ āĻ•āĻžāĻ āĻŋāĻ¨ā§āϝ āĻĒā§āϰāϧāĻžāύ āϏāĻŽāĻ¸ā§āϝāĻž āĻšā§ŸāĨ¤

Clinical limitation: IBS-C āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇ Rome IV symptom criteria āĻĒā§‚āϰāĻŖ āĻšāϤ⧇ āĻšāĻŦ⧇āĨ¤ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āϏ⧇āχ āχāϤāĻŋāĻšāĻžāϏ āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āύ⧇āχāĨ¤ āϤāĻžāχ IBS-C-āϕ⧇ documented working diagnosis āĻšāĻŋāϏ⧇āĻŦ⧇ āϧāϰāĻž āϝāĻĨāĻžāϝāĻĨ, confirmed diagnosis āĻšāĻŋāϏ⧇āĻŦ⧇ āύ⧟āĨ¤

Diagnosis 2: Enlarged Prostate

āĻŦ⧟āĻ¸ā§āĻ• āĻĒ⧁āϰ⧁āώ⧇āϰ āĻĒā§āϰāĻ¸ā§āϰāĻžāĻŦ⧇āϰ āϏāĻŽāĻ¸ā§āϝāĻž āĻāĻŦāĻ‚ enlarged prostate-āĻāϰ diagnosis Benign Prostatic Hyperplasia (BPH)-āĻāϰ āϏāĻ™ā§āϗ⧇ āϏāĻžāĻŽāĻžā§āϜāĻ¸ā§āϝāĻĒā§‚āĻ°ā§āĻŖāĨ¤

āϤāĻŦ⧇ enlarged prostate āĻāĻŦāĻ‚ histologically confirmed BPH āĻāĻ• āĻŦāĻŋāώ⧟ āύ⧟āĨ¤ Prostate enlargement-āĻāϰ āĻĒāĻžāĻļāĻžāĻĒāĻžāĻļāĻŋ urinary symptoms-āĻāϰ āĻ…āĻ¨ā§āϝ āĻ•āĻžāϰāĻŖāĻ“ āĻŦāĻžāĻĻ āĻĻāĻŋāϤ⧇ āĻšāĻŦ⧇āĨ¤

Diagnosis 3: Anxiety Disorder

āĻ…āύāĻŋāĻĻā§āϰāĻž, āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻŦ⧁āĻ• āϧ⧜āĻĢ⧜ āĻ•āϰāĻž āĻāĻŦāĻ‚ āωāĻĻā§āĻŦ⧇āĻ—āϜāύāĻŋāϤ āωāĻĒāϏāĻ°ā§āĻ— anxiety disorder-āĻāϰ āϏāĻ™ā§āϗ⧇ āϏāĻžāĻŽāĻžā§āϜāĻ¸ā§āϝāĻĒā§‚āĻ°ā§āĻŖ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻŦ⧇ anxiety disorder-āĻāϰ subtype āύāĻŋāĻ°ā§āϧāĻžāϰāϪ⧇āϰ āϜāĻ¨ā§āϝ āĻŦāĻŋāĻ¸ā§āϤāĻžāϰāĻŋāϤ psychiatric history āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤


5. Investigations — āĻĄāĻžāĻ•ā§āϤāĻžāϰ āϕ⧀ āϕ⧀ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻĻāĻŋā§Ÿā§‡āϛ⧇āύ?

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇āϰ āĻŽāĻžāĻāĻ–āĻžāύ⧇ āĻĻ⧁āϟāĻŋ investigation āϤ⧁āϞāύāĻžāĻŽā§‚āϞāĻ•āĻ­āĻžāĻŦ⧇ āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰāĨ¤

1. Colonoscopy

āĻŦāĻžāĻ‚āϞāĻž: āĻŦ⧃āĻšāĻĻāĻ¨ā§āĻ¤ā§āϰ⧇āϰ āϭ⧇āϤāϰ āĻ•ā§āϝāĻžāĻŽā§‡āϰāĻžāϰ āϏāĻžāĻšāĻžāĻ¯ā§āϝ⧇ āĻĒāϰ⧀āĻ•ā§āώāĻžāĨ¤

Purpose:

  • Colorectal malignancy āĻŦāĻž polyp āĻŽā§‚āĻ˛ā§āϝāĻžā§ŸāύāĨ¤
  • āĻĻā§€āĻ°ā§āϘāĻ¸ā§āĻĨāĻžā§Ÿā§€ bowel symptoms-āĻāϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ structural cause āĻļāύāĻžāĻ•ā§āϤ āĻ•āϰāĻžāĨ¤
  • āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϞ⧇ biopsy āύ⧇āĻ“ā§ŸāĻžāĨ¤

Why relevant? ā§­ā§Ļ āĻŦāĻ›āϰ āĻŦ⧟āϏ⧀ āϰ⧋āĻ—ā§€āϰ bowel habit āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāĻŋāϤ āĻšāϞ⧇ āĻļ⧁āϧ⧁ IBS āϧāϰ⧇ āύ⧇āĻ“ā§ŸāĻžāϰ āφāϗ⧇ organic pathology āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āϜāϰ⧁āϰāĻŋāĨ¤

2. NCV Study of Both Lower Limbs

Full form: Nerve Conduction Velocity Study.

āĻŦāĻžāĻ‚āϞāĻž: āωāϭ⧟ āĻĒāĻžā§Ÿā§‡āϰ āĻ¸ā§āύāĻžā§Ÿā§āϰ āĻŦ⧈āĻĻā§āϝ⧁āϤāĻŋāĻ• āĻĒāϰāĻŋāĻŦāĻžāĻšāĻŋāϤāĻž āĻĒāϰ⧀āĻ•ā§āώāĻžāĨ¤

Purpose:

  • Peripheral neuropathy āĻŽā§‚āĻ˛ā§āϝāĻžā§ŸāύāĨ¤
  • Neuropathic symptoms-āĻāϰ āĻĒā§āϰāĻ•ā§ƒāϤāĻŋ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖāĨ¤
  • āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϏāĻžāϰ⧇ EMG-āĻāϰ āϏāĻ™ā§āϗ⧇ āĻ¸ā§āύāĻžā§Ÿā§āϰ āϏāĻŽāĻ¸ā§āϝāĻžāϰ āĻŽā§‚āĻ˛ā§āϝāĻžā§ŸāύāĨ¤

Additional Note

Advice box-āĻāϰ āύāĻŋāĻšā§‡āϰ āϞ⧇āĻ–āĻžāϟāĻŋ āϏāĻŽā§āĻ­āĻŦāϤ specialist referral-āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ, āϤāĻŦ⧇ āύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āĻĒ⧜āĻž āϝāĻžāĻšā§āϛ⧇ āύāĻžāĨ¤ āϤāĻžāχ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ referral āĻŦāĻž procedure-āĻāϰ āύāĻžāĻŽ āĻ…āύ⧁āĻŽāĻžāύ āĻ•āϰ⧇ āϝ⧁āĻ•ā§āϤ āĻ•āϰāĻ›āĻŋ āύāĻžāĨ¤


6. Prescribed Drug Analysis — MedEx Bangladesh

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āĻŽā§‹āϟ āĻĒāĻžāρāϚāϟāĻŋ āĻ“āώ⧁āϧ āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžāĻšā§āϛ⧇āĨ¤

No. Brand Name Generic Name Strength
1 Motigut Domperidone Maleate 10 mg
2 Timotor Trimebutine Maleate 100 mg
3 Lubilax Lubiprostone Strength unclear
4 Nexcital Escitalopram Oxalate 10 mg
5 Uromax-D Tamsulosin + Dutasteride 0.4 mg + 0.5 mg

āĻŦā§āĻ°ā§āϝāĻžāĻ¨ā§āĻĄāϗ⧁āϞ⧋āϰ spelling āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ āĻ“ MedEx āĻŽāĻŋāϞāĻŋā§Ÿā§‡ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤

1. Motigut 10 mg Tablet

Bangladesh Brand Name: Motigut 10 mg

Manufacturer: Square Pharmaceuticals PLC

Generic Name: Domperidone Maleate 10 mg

MedEx Therapeutic Class: Motility Stimulants; Motility stimulants/Dopamine antagonist; Prokinetic drugs.

Pharmacological Class: Peripheral dopamine D₂-receptor antagonist.

Use of Purpose:

Domperidone āĻĒā§āϰāϧāĻžāύāϤ nausea, vomiting āĻāĻŦāĻ‚ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ upper gastrointestinal motility-related symptoms-āĻāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžā§Ÿ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§ŸāĨ¤

Why Doctor Prescribed This Drug:

āϰ⧋āĻ—ā§€āϰ gastrointestinal symptoms āĻŦāĻŋāĻŦ⧇āϚāύāĻžā§Ÿ dyspepsia āĻŦāĻž upper abdominal discomfort āωāĻĒāĻļāĻŽā§‡āϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ āĻ“āώ⧁āϧāϟāĻŋ āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§Ÿā§‡ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻŦ⧇ āĻāϟāĻŋ IBS-C āĻŦāĻž āϕ⧋āĻˇā§āĻ āĻ•āĻžāĻ āĻŋāĻ¨ā§āϝ⧇āϰ āĻŽā§‚āϞ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āύ⧟āĨ¤

Available Composition: Tablet 10 mg, suspension 5 mg/5 mL āĻāĻŦāĻ‚ paediatric drops 5 mg/mLāĨ¤

Price:

  • Unit Price: ā§ŗ4.00
  • Strip Price (10 tablets): ā§ŗ40.00

Motigut 10 mg — MedEx

Important safety consideration: āĻŦ⧟āĻ¸ā§āĻ• āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ Domperidone-āĻāϰ cardiac arrhythmia āĻ“ QT prolongation-āĻāϰ āĻā§āρāĻ•āĻŋ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤ āĻŦāĻ°ā§āϤāĻŽāĻžāύ āχāωāϰ⧋āĻĒā§€ā§Ÿ regulatory advice āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻāϟāĻŋ āĻŽā§‚āϞāϤ nausea āĻ“ vomiting-āĻāϰ āĻ¸ā§āĻŦāĻ˛ā§āĻĒāĻŽā§‡ā§ŸāĻžāĻĻāĻŋ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžā§Ÿ āϏ⧀āĻŽāĻŋāϤ āϰāĻžāĻ–āĻž āĻšā§ŸāĨ¤

2. Timotor 100 mg Tablet

Bangladesh Brand Name: Timotor 100 mg

Manufacturer: Square Pharmaceuticals PLC

Generic Name: Trimebutine Maleate 100 mg

MedEx Therapeutic Class: Anticholinergics.

Pharmacological Class: Gastrointestinal motility regulator and noncompetitive spasmolytic agent.

Use of Purpose:

Trimebutine āĻ…āĻ¨ā§āĻ¤ā§āϰ⧇āϰ āĻ…āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• motility āύāĻŋ⧟āĻ¨ā§āĻ¤ā§āϰāĻŖ āĻāĻŦāĻ‚ IBS-associated abdominal discomfort āωāĻĒāĻļāĻŽā§‡āϰ āϜāĻ¨ā§āϝ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§ŸāĨ¤

Why Doctor Prescribed This Drug:

āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ IBS-C diagnosis-āĻāϰ āϏāĻ™ā§āϗ⧇ āĻāϟāĻŋ āϏāĻžāĻŽāĻžā§āϜāĻ¸ā§āϝāĻĒā§‚āĻ°ā§āĻŖāĨ¤ āĻŦāĻŋāĻļ⧇āώāϤ āĻĒ⧇āϟāĻŦā§āϝāĻĨāĻž, cramping āĻŦāĻž intestinal motility disturbance āĻĨāĻžāĻ•āϞ⧇ symptomatic relief-āĻāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ⧇ āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§Ÿā§‡ āĻĨāĻžāĻ•āϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻŦ⧇ Trimebutine IBS-C-āĻāϰ āϕ⧋āĻˇā§āĻ āĻ•āĻžāĻ āĻŋāĻ¨ā§āϝ⧇āϰ āϜāĻ¨ā§āϝ guideline-preferred primary laxative āύ⧟āĨ¤

Available Composition: 100 mg tablet.

Price:

  • Unit Price: ā§ŗ6.00
  • Strip Price (10 tablets): ā§ŗ60.00

Bangladesh Alternative Brands: Trimotil 100 mg āĻāĻŦāĻ‚ Tritin 100 mgāĨ¤

Timotor 100 mg — MedEx

3. Lubilax Capsule

Bangladesh Brand Name: Lubilax

Manufacturer: Beacon Pharmaceuticals PLC

Generic Name: Lubiprostone.

MedEx Therapeutic Class: Other laxative preparations.

Pharmacological Class: Intestinal chloride-channel activator; secretagogue.

Use of Purpose:

Lubiprostone āĻ…āĻ¨ā§āĻ¤ā§āϰ⧇ āϤāϰāϞ āύāĻŋāσāϏāϰāĻŖ āĻŦāĻžā§œāĻŋā§Ÿā§‡ āĻŽāϞ āύāϰāĻŽ āĻ•āϰāϤ⧇ āĻāĻŦāĻ‚ bowel movement āϏāĻšāϜ āĻ•āϰāϤ⧇ āϏāĻžāĻšāĻžāĻ¯ā§āϝ āĻ•āϰ⧇āĨ¤

āĻāϟāĻŋ āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§Ÿ:

  1. Chronic Idiopathic Constipation (CIC)
  2. Opioid-Induced Constipation
  3. IBS-C — āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻ…āύ⧁āĻŽā§‹āĻĻāĻŋāϤ āϰ⧋āĻ—ā§€āĻ—ā§‹āĻˇā§āĻ ā§€āϤ⧇

Why Doctor Prescribed This Drug:

āϰ⧋āĻ—ā§€āϰ āĻĒā§āϰāϧāĻžāύ gastrointestinal āϏāĻŽāĻ¸ā§āϝāĻž āϝāĻĻāĻŋ chronic constipation āĻšā§Ÿ, āϤāĻžāĻšāϞ⧇ Lubiprostone āĻĻ⧇āĻ“ā§ŸāĻžāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ āϝ⧌āĻ•ā§āϤāĻŋāĻ•āĨ¤

Available Composition and Price:

Strength Unit Price Strip Price
Lubilax 8 mcg ā§ŗ15.05 ā§ŗ150.50
Lubilax 24 mcg ā§ŗ40.12 ā§ŗ401.20

Important: āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ Lubilax-āĻāϰ strength āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ āύ⧟āĨ¤

āĻāĻ•āϜāύ āĻĒ⧁āϰ⧁āώ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ IBS-C-āĻāϰ āϜāĻ¨ā§āϝ 8 mcg dosing-āĻāϰ FDA approval āύ⧇āχāĨ¤ āϤāĻŦ⧇ āĻĒā§āϰāĻžāĻĒā§āϤāĻŦ⧟āĻ¸ā§āĻ•āĻĻ⧇āϰ Chronic Idiopathic Constipation-āĻāϰ āϜāĻ¨ā§āϝ 24 mcg twice daily āĻāĻ•āϟāĻŋ āĻ…āύ⧁āĻŽā§‹āĻĻāĻŋāϤ regimenāĨ¤

āϏ⧁āϤāϰāĻžāĻ‚ āϰ⧋āĻ—ā§€āϰ āϏāĻ āĻŋāĻ• diagnosis āĻāĻŦāĻ‚ prescribed strength āϝāĻžāϚāĻžāχ āĻ•āϰāĻž āϜāϰ⧁āϰāĻŋāĨ¤ Mechanical bowel obstruction āĻĨāĻžāĻ•āϞ⧇ Lubiprostone āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻž āϝāĻžāĻŦ⧇ āύāĻžāĨ¤

Lubilax 24 mcg — MedEx

4. Nexcital 10 mg Tablet

Bangladesh Brand Name: Nexcital 10 mg

Manufacturer: UniMed UniHealth Pharmaceuticals Ltd.

Generic Name: Escitalopram Oxalate 10 mg

MedEx Therapeutic Class: SSRIs & related anti-depressant drugs.

Pharmacological Class: Selective Serotonin Reuptake Inhibitor (SSRI).

Use of Purpose:

Escitalopram āĻŦā§āϝāĻŦāĻšā§ƒāϤ āĻšā§Ÿ:

  • Major Depressive Disorder
  • Generalized Anxiety Disorder
  • Panic Disorder
  • Social Anxiety Disorder
  • Obsessive-Compulsive Disorder

Why Doctor Prescribed This Drug:

āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• Anxiety Disorder āϞāĻŋāϖ⧇āϛ⧇āύāĨ¤ āϤāĻžāχ anxiety symptoms āύāĻŋ⧟āĻ¨ā§āĻ¤ā§āϰāϪ⧇āϰ āϜāĻ¨ā§āϝ Escitalopram āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§Ÿā§‡āϛ⧇ āĻŦāϞ⧇ āĻŽāύ⧇ āĻšāĻšā§āϛ⧇āĨ¤

āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āĻĒā§āϰāĻĨāĻŽā§‡ āϏāĻŽā§āĻ­āĻŦāϤ ÂŊ tablet āĻāĻŦāĻ‚ āĻĒāϰ⧇ ā§§ tablet āĻĻ⧈āύāĻŋāĻ• āύ⧇āĻ“ā§ŸāĻžāϰ āύāĻŋāĻ°ā§āĻĻ⧇āĻļ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤ āϤāĻŦ⧇ āĻŽā§‚āϞ dose schedule āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āϞāĻŋāĻ–āĻŋāϤ āφāĻĻ⧇āĻļ āĻĨ⧇āϕ⧇ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Available Composition: 5 mg āĻ“ 10 mg tablets.

Price:

  • Unit Price: ā§ŗ13.00
  • Strip Price (10 tablets): ā§ŗ130.00

Nexcital 10 mg — MedEx

Important: āĻŦ⧟āĻ¸ā§āĻ• āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ Escitalopram-āĻāϰ starting dose, serum sodium, QT risk āĻāĻŦāĻ‚ āĻ…āĻ¨ā§āϝ āĻ“āώ⧁āϧ⧇āϰ āϏāĻ™ā§āϗ⧇ interaction āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āϜāϰ⧁āϰāĻŋāĨ¤

5. Uromax-D Capsule

Bangladesh Brand Name: Uromax-D

Manufacturer: UniMed UniHealth Pharmaceuticals Ltd.

Generic Composition:

  • Tamsulosin Hydrochloride 0.4 mg
  • Dutasteride 0.5 mg

MedEx Therapeutic Class: BPH/ Urinary retention/ Urinary incontinence.

Pharmacological Classes:

  • Tamsulosin — Selective α₁-adrenergic receptor antagonist
  • Dutasteride — 5Îą-reductase inhibitor

Use of Purpose:

Tamsulosin āĻĒā§āϰ⧋āĻ¸ā§āĻŸā§‡āϟ āĻ“ bladder neck-āĻāϰ smooth muscle relax āĻ•āϰ⧇ āĻĒā§āϰāĻ¸ā§āϰāĻžāĻŦ⧇āϰ āĻĒā§āϰāĻŦāĻžāĻš āϏāĻšāϜ āĻ•āϰ⧇āĨ¤

Dutasteride dihydrotestosterone āĻ‰ā§ŽāĻĒāĻžāĻĻāύ āĻ•āĻŽāĻŋā§Ÿā§‡ āĻĻā§€āĻ°ā§āϘāĻŽā§‡ā§ŸāĻžāĻĻ⧇ prostate volume āĻ•āĻŽāĻžāϤ⧇ āϏāĻžāĻšāĻžāĻ¯ā§āϝ āĻ•āϰ⧇āĨ¤

Why Doctor Prescribed This Drug:

āϰ⧋āĻ—ā§€āϰ Enlarged Prostate diagnosis āĻāĻŦāĻ‚ urinary complaints-āĻāϰ āϏāĻ™ā§āϗ⧇ āĻ“āώ⧁āϧāϟāĻŋāϰ āĻŦā§āϝāĻŦāĻšāĻžāϰ āϏāĻžāĻŽāĻžā§āϜāĻ¸ā§āϝāĻĒā§‚āĻ°ā§āĻŖāĨ¤

āĻāϟāĻŋ āĻŦāĻŋāĻļ⧇āώāĻ­āĻžāĻŦ⧇ āĻŦāĻŋāĻŦ⧇āϚāĻŋāϤ āĻšā§Ÿ āϝāĻ–āύ BPH-related moderate-to-severe LUTS āĻāĻŦāĻ‚ disease progression-āĻāϰ āĻā§āρāĻ•āĻŋ āĻĨāĻžāϕ⧇āĨ¤

Price:

  • Unit Price: ā§ŗ23.00
  • 5 capsules-āĻāϰ āφāύ⧁āĻŽāĻžāύāĻŋāĻ• strip price: ā§ŗ115.00

Available Similar Brands: Maxrin D, Prostacin D, Uroflo Plus, Urocap-D āĻ“ Uropass-DāĨ¤

Uromax-D and Alternative Brands — MedEx

Clinical caution: Tamsulosin-āĻāϰ āĻ•āĻžāϰāϪ⧇ orthostatic hypotension āĻ“ dizziness āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ Dutasteride āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇ PSA interpretation āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāĻŋāϤ āĻšā§Ÿ āĻāĻŦāĻ‚ prostate size āĻ“ symptom response āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ⧇ āĻĻā§€āĻ°ā§āϘāĻŽā§‡ā§ŸāĻžāĻĻāĻŋ follow-up āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤


7. âš ī¸ Critical Prescription Safety Review

Potentially Important Drug Interaction

Motigut (Domperidone) + Nexcital (Escitalopram)

āĻāχ combination-āĻ āĻĻ⧁āϟāĻŋ āĻ“āώ⧁āϧāχ QT interval āĻĻā§€āĻ°ā§āϘāĻžā§ŸāĻŋāϤ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻŦāĻŋāĻļ⧇āώāϤ ā§­ā§Ļ āĻŦāĻ›āϰ āĻŦ⧟āϏ⧀ āϰ⧋āĻ—ā§€āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇:

  • Cardiac arrhythmia
  • Syncope
  • Torsades de pointes-āĻāϰ āĻŽāϤ⧋ āϗ⧁āϰ⧁āϤāϰ ventricular arrhythmia

āĻāϰ āĻā§āρāĻ•āĻŋ āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Clinical assessment: āĻŦāĻ°ā§āϤāĻŽāĻžāύ EMA āĻ“ MHRA safety recommendations āĻ…āύ⧁āϝāĻžā§Ÿā§€, QT-prolonging āĻ“āώ⧁āϧ⧇āϰ āϏāĻ™ā§āϗ⧇ Domperidone-āĻāϰ āϏāĻšāĻŦā§āϝāĻŦāĻšāĻžāϰ contraindicated āĻšāĻŋāϏ⧇āĻŦ⧇ āĻŦāĻŋāĻŦ⧇āϚāĻŋāϤāĨ¤ Escitalopram-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇āĻ“ QT-prolonging āĻ“āώ⧁āϧ⧇āϰ āϏāĻ™ā§āϗ⧇ combination āĻā§œāĻžāύ⧋āϰ āύāĻŋāĻ°ā§āĻĻ⧇āĻļ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

Recommended action: āϰ⧋āĻ—ā§€ āĻŦāĻ°ā§āϤāĻŽāĻžāύ⧇ āĻāχ āĻ“āώ⧁āϧāϗ⧁āϞ⧋ āĻ–ā§‡ā§Ÿā§‡ āĻĨāĻžāĻ•āϞ⧇ prescribing physician-āĻāϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āĻĻā§āϰ⧁āϤ medication reconciliation āĻāĻŦāĻ‚ āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤ ECG āĻ“ serum electrolytes āĻĒāϰ⧀āĻ•ā§āώāĻž āĻŦāĻŋāĻŦ⧇āĻšā§āϝāĨ¤

āĻāϟāĻŋ āĻĒ⧁āϰ⧋āύ⧋ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ āĻšāĻ“ā§ŸāĻžā§Ÿ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻĒ⧁āύāĻ°ā§āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻ›āĻžā§œāĻž āĻ“āώ⧁āϧāϗ⧁āϞ⧋ āύāϤ⧁āύ āĻ•āϰ⧇ āĻļ⧁āϰ⧁ āĻ•āϰāĻž āωāϚāĻŋāϤ āύ⧟āĨ¤


8. My Clinical Working Assessment

Doctor's Dx āĻŦāύāĻžāĻŽ Independent Clinical Assessment

Clinical condition Doctor's Dx My assessment Agreement
IBS-C IBS-C Suspected IBS-C; CIC remains an important alternative Partial
Enlarged Prostate Enlarged Prostate Probable BPH-associated LUTS Substantial
Anxiety Disorder Anxiety Disorder Possible anxiety disorder requiring formal assessment Partial
Bilateral leg paraesthesia No definite diagnosis visible Peripheral neuropathy to be evaluated Not separately established

1. IBS-C versus Chronic Idiopathic Constipation

āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• IBS-C āϞāĻŋāϖ⧇āϛ⧇āύāĨ¤

āĻ•āĻŋāĻ¨ā§āϤ⧁ IBS-C āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻžāϰ āϜāĻ¨ā§āϝ recurrent abdominal pain-āĻāϰ āϏāĻ™ā§āϗ⧇ stool frequency āĻ…āĻĨāĻŦāĻž stool form āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ⧇āϰ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϏāĻŽā§āĻĒāĻ°ā§āĻ• āĻĨāĻžāĻ•āϤ⧇ āĻšāĻŦ⧇āĨ¤

āĻāĻ–āĻžāύ⧇ āϤāĻž āĻ¸ā§āĻĒāĻˇā§āϟ āύ⧟āĨ¤

āϏ⧁āϤāϰāĻžāĻ‚ āφāĻŽāĻžāϰ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ⧇:

IBS-C and CIC are competing possibilities.

āϕ⧋āĻˇā§āĻ āĻ•āĻžāĻ āĻŋāĻ¨ā§āϝ āĻĒā§āϰāϧāĻžāύ āωāĻĒāϏāĻ°ā§āĻ— āĻšāϞ⧇āĻ“ recurrent abdominal pain-āĻāϰ āωāĻĒāϝ⧁āĻ•ā§āϤ āχāϤāĻŋāĻšāĻžāϏ āύāĻž āĻĨāĻžāĻ•āϞ⧇ CIC āĻ…āϧāĻŋāĻ• āωāĻĒāϝ⧁āĻ•ā§āϤ diagnosis āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

2. Enlarged Prostate versus BPH

āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ Enlarged Prostate diagnosis-āĻāϰ āϏāĻ™ā§āϗ⧇ āφāĻŽāĻŋ āĻāĻ•āĻŽāϤ āϝ⧇ BPH-associated urinary symptoms āĻāĻ•āϟāĻŋ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻžāĨ¤

āϤāĻŦ⧇ prostate volume, DRE, PVR āĻāĻŦāĻ‚ urinary investigations āĻ›āĻžā§œāĻž bladder outlet obstruction āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤

3. Anxiety Disorder

āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ diagnosis āϏāĻŽā§āĻ­āĻžāĻŦā§āϝāĨ¤

āĻ•āĻŋāĻ¨ā§āϤ⧁ GAD-7 assessment, symptom duration, functional impairment āĻāĻŦāĻ‚ depression screening āĻ›āĻžā§œāĻž āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ anxiety disorder subtype āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϏāĻŽā§āĻ­āĻŦ āύ⧟āĨ¤

Additional Clinical Possibility

āωāϭ⧟ āĻĒāĻžā§Ÿā§‡ āĻāĻŋāύāĻāĻŋāύ āĻ…āύ⧁āĻ­ā§‚āϤāĻŋāϰ āĻ•āĻžāϰāϪ⧇ Peripheral Neuropathy āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻ•āĻžāϰāĻŖ:

  • Diabetes mellitus
  • Vitamin B12 deficiency
  • Hypothyroidism
  • Chronic kidney disease
  • Neurological disorders

āĻāϏāĻŦ āϕ⧇āĻŦāϞ differential diagnosis; āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ āĻĨ⧇āϕ⧇ āĻāϗ⧁āϞ⧋ āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤


9. Final Working Clinical Diagnosis

āĻŦāĻ°ā§āϤāĻŽāĻžāύ āϤāĻĨā§āϝ⧇āϰ āĻ­āĻŋāĻ¤ā§āϤāĻŋāϤ⧇ āφāĻŽāĻŋ āύāĻŋāĻšā§‡āϰ working diagnosis āĻŦā§āϝāĻŦāĻšāĻžāϰ āĻ•āϰāĻŦāĨ¤

Primary Working Diagnosis:

Suspected IBS-C versus Chronic Idiopathic Constipation (CIC).

Associated Conditions:

Probable Benign Prostatic Enlargement with Lower Urinary Tract Symptoms (LUTS).

Possible Anxiety Disorder with Insomnia.

Bilateral Lower Limb Paraesthesia — Peripheral Neuropathy to be evaluated.

āĻŦāĻžāĻ‚āϞāĻž Diagnosis

ā§§. āϕ⧋āĻˇā§āĻ āĻ•āĻžāĻ āĻŋāĻ¨ā§āϝ-āĻĒā§āϰāϧāĻžāύ āχāϰāĻŋāĻŸā§‡āĻŦāϞ āĻŦāĻžāĻ“ā§Ÿā§‡āϞ āϏāĻŋāĻ¨ā§āĻĄā§āϰ⧋āĻŽ āϏāĻ¨ā§āĻĻ⧇āĻš; āĻŦāĻŋāĻ•āĻ˛ā§āĻĒāĻ­āĻžāĻŦ⧇ āĻĻā§€āĻ°ā§āϘāĻ¸ā§āĻĨāĻžā§Ÿā§€ āĻ…āĻœā§āĻžāĻžāϤāĻ•āĻžāϰāĻŖ āϕ⧋āĻˇā§āĻ āĻ•āĻžāĻ āĻŋāĻ¨ā§āϝāĨ¤

⧍. āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻŦāĻŋāύāĻžāχāύ āĻĒā§āϰ⧋āĻ¸ā§āĻŸā§‡āϟ āĻŦ⧃āĻĻā§āϧāĻŋ āĻāĻŦāĻ‚ āĻāϰ āϏāĻ™ā§āϗ⧇ āύāĻŋāĻŽā§āύ āĻŽā§‚āĻ¤ā§āϰāύāĻžāϞāĻŋāϰ āωāĻĒāϏāĻ°ā§āĻ—āĨ¤

ā§Š. āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āωāĻĻā§āĻŦ⧇āĻ—āϜāύāĻŋāϤ āĻŽāĻžāύāϏāĻŋāĻ• āĻŦā§āϝāĻžāϧāĻŋ āĻ“ āĻ…āύāĻŋāĻĻā§āϰāĻžāĨ¤

ā§Ē. āωāϭ⧟ āĻĒāĻžā§Ÿā§‡ āĻ…āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻ…āύ⧁āĻ­ā§‚āϤāĻŋ; āĻĒ⧇āϰāĻŋāĻĢ⧇āϰāĻžāϞ āύāĻŋāωāϰ⧋āĻĒā§āϝāĻžāĻĨāĻŋ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

Diagnostic Confidence

Assessment Confidence
Prescription contains IBS-C as a working Dx 0.85
Enlarged prostate is documented 0.95
Anxiety disorder is documented 0.90
Actual IBS-C diagnosis is confirmed Insufficient evidence
Actual BPH-related obstruction is confirmed Insufficient evidence
Peripheral neuropathy is confirmed Insufficient evidence

āĻāĻ–āĻžāύ⧇ āϏāĻ‚āĻ–ā§āϝāĻžāϗ⧁āϞ⧋ āĻŽā§‚āϞāϤ handwriting interpretation-āĻāϰ confidence, āϰ⧋āĻ— āύāĻŋāĻ°ā§āĻŖā§Ÿā§‡āϰ āĻĒāϰāĻŋāϏāĻ‚āĻ–ā§āϝāĻžāύāĻ—āϤ probability āύ⧟āĨ¤


10. Further Investigations — Recommended

Gastrointestinal Assessment

  1. CBC — Anaemia āĻļāύāĻžāĻ•ā§āϤ āĻ•āϰāĻžāϰ āϜāĻ¨ā§āϝāĨ¤
  2. TSH — Hypothyroidism-associated constipation āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ⧇āĨ¤
  3. Serum calcium āĻ“ electrolytes — Metabolic contributors āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ⧇āĨ¤
  4. Colonoscopy — āĻŦ⧟āϏ, screening history āĻ“ alarm features āĻ…āύ⧁āϝāĻžā§Ÿā§€āĨ¤
  5. Stool occult blood/FIT — āĻĒā§āϰāĻžāϏāĻ™ā§āĻ—āĻŋāĻ• clinical indication āĻ…āύ⧁āϝāĻžā§Ÿā§€āĨ¤

Urological Assessment

  1. Urine R/M/E
  2. Urine culture — UTI āϏāĻ¨ā§āĻĻ⧇āĻš āĻšāϞ⧇āĨ¤
  3. Serum creatinine/eGFR
  4. USG KUB with prostate volume and post-void residual urine
  5. PSA — Shared decision-making āĻ“ management relevance āĻ…āύ⧁āϝāĻžā§Ÿā§€āĨ¤
  6. Uroflowmetry

EAU Guidelines āĻ…āύ⧁āϝāĻžā§Ÿā§€ male LUTS āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ⧇ history, symptom scoring, urinalysis, examination āĻāĻŦāĻ‚ post-void residual assessment āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤

Neurological Assessment

  1. NCV study
  2. HbA1c
  3. Serum vitamin B12
  4. TSH
  5. Renal function
  6. Neurological examination; āĻĒā§āĻ°ā§Ÿā§‹āϜāύ⧇ EMG

11. Bangladesh Clinical Practice — Commonly Used Medicines

āύāĻŋāĻšā§‡āϰ āĻ“āώ⧁āϧāϗ⧁āϞ⧋ āĻāχ āϧāϰāύ⧇āϰ āϰ⧋āϗ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžā§Ÿ āĻŦāĻžāĻ‚āϞāĻžāĻĻ⧇āĻļ⧇ āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāĨ¤ āĻāϗ⧁āϞ⧋ āĻāĻ•āϏāĻ™ā§āϗ⧇ āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇āϰ āϤāĻžāϞāĻŋāĻ•āĻž āύ⧟; āϰ⧋āĻ—ā§€āϰ āϏ⧁āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ diagnosis, contraindications āĻāĻŦāĻ‚ response āĻ…āύ⧁āϝāĻžā§Ÿā§€ āύāĻŋāĻ°ā§āĻŦāĻžāϚāύ āĻ•āϰāϤ⧇ āĻšā§ŸāĨ¤

Disease Generic Drug Bangladesh Brand Examples Clinical Purpose
IBS-related symptoms Trimebutine Timotor, Trimotil, Tritin Bowel spasm āĻ“ IBS symptoms
Chronic constipation Lubiprostone Lubilax, Lubistone, Lubigut Intestinal fluid secretion āĻŦ⧃āĻĻā§āϧāĻŋ
Chronic constipation Polyethylene glycol Generic-specific local brands Osmotic laxative
Chronic constipation Lactulose Generic-specific local brands Stool softening via osmotic action
Chronic constipation Prucalopride Mopride, Motelity Colonic motility āĻŦ⧃āĻĻā§āϧāĻŋ
BPH-associated LUTS Tamsulosin Uromax, Uroflo, Urocap Urinary flow improvement
BPH-associated LUTS Dutasteride Urodart Prostate volume reduction
BPH-associated LUTS Tamsulosin + Dutasteride Uromax-D, Maxrin D, Urocap-D Combination therapy in selected patients
Anxiety disorder Escitalopram Nexcital, Oxapro, Losita Anxiety symptoms
Anxiety disorder Sertraline Generic-specific local brands Anxiety/depression treatment

Guideline-based point: AGA–ACG 2023 chronic constipation guideline PEG āĻŦā§āϝāĻŦāĻšāĻžāϰ⧇ āĻļāĻ•ā§āϤāĻŋāĻļāĻžāϞ⧀ recommendation āĻĻāĻŋā§Ÿā§‡āϛ⧇āĨ¤ OTC therapy-āϤ⧇ āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ āωāĻ¨ā§āύāϤāĻŋ āύāĻž āĻšāϞ⧇ Lubiprostone, Linaclotide āĻ…āĻĨāĻŦāĻž Prucalopride-āĻāϰ āĻŽāϤ⧋ āĻ“āώ⧁āϧ clinical context āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āϝāĻžā§ŸāĨ¤

BPH-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ Tamsulosin + Dutasteride combination āϏāĻžāϧāĻžāϰāĻŖāϤ enlarged prostate āĻ“ progression risk āĻĨāĻžāĻ•āϞ⧇ āĻŦ⧇āĻļāĻŋ āωāĻĒāϝ⧋āĻ—ā§€āĨ¤


12. Management and Treatment Plan

A. Constipation / Suspected IBS-C

āĻĒā§āϰāĻĨāĻŽā§‡ Rome IV symptom history āϝāĻžāϚāĻžāχ āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤

Management options:

  • Dietary fibre gradually increase āĻ•āϰāĻžāĨ¤
  • āĻĒāĻ°ā§āϝāĻžāĻĒā§āϤ hydration āĻŦāϜāĻžā§Ÿ āϰāĻžāĻ–āĻžāĨ¤
  • Regular physical activityāĨ¤
  • Toilet routine āĻ“ bowel habit correctionāĨ¤
  • āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ soluble fibre āĻŦāĻž PEGāĨ¤
  • Refractory constipation-āĻ prescription medication āĻŦāĻŋāĻŦ⧇āϚāύāĻžāĨ¤

Important: āϰ⧋āĻ—ā§€ āϝāĻĻāĻŋ āĻāĻ–āύ⧋ colonoscopy āύāĻž āĻ•āϰ⧇ āĻĨāĻžāϕ⧇āύ āĻāĻŦāĻ‚ āύāϤ⧁āύ bowel symptoms, rectal bleeding, unexplained weight loss āĻŦāĻž anaemia āĻĨāĻžāϕ⧇, āϤāĻžāĻšāϞ⧇ āĻĻā§āϰ⧁āϤ Gastroenterology assessment āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

B. BPH-associated LUTS

  • IPSS assessmentāĨ¤
  • Urinalysis āĻ“ PVRāĨ¤
  • Prostate volume measurementāĨ¤
  • Alpha-blocker suitability assessmentāĨ¤
  • Significant prostate enlargement āĻĨāĻžāĻ•āϞ⧇ 5Îą-reductase inhibitor āĻŦāĻŋāĻŦ⧇āϚāύāĻžāĨ¤
  • Treatment response āĻāĻŦāĻ‚ adverse effects follow-upāĨ¤

C. Anxiety Disorder

  • GAD-7 assessmentāĨ¤
  • Depression screeningāĨ¤
  • Sleep assessmentāĨ¤
  • Cognitive Behavioural Therapy (CBT) āĻŦāĻŋāĻŦ⧇āϚāύāĻžāĨ¤
  • āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϞ⧇ SSRI therapyāĨ¤
  • Elderly patient-āĻāϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ ECG, electrolytes āĻ“ drug interaction reviewāĨ¤

13. Which Specialist Should Be Consulted?

Clinical Problem Recommended Specialist
IBS-C / Chronic Constipation Gastroenterologist
Enlarged Prostate / Urinary Symptoms Urologist
Anxiety Disorder Psychiatrist
Bilateral Leg Paraesthesia Neurologist

Referral Priority

āĻĒā§āϰāĻĨāĻŽā§‡ Gastroenterologist āĻāĻŦāĻ‚ Urologist-āĻāϰ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤

āĻ•āĻžāϰāĻŖ āϰ⧋āĻ—ā§€āϰ āĻŦ⧟āϏ āĻŦ⧇āĻļāĻŋ āĻāĻŦāĻ‚ āĻāĻ•āχ āϏāĻ™ā§āϗ⧇ bowel āĻ“ urinary symptoms āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

Neurological symptoms āϝāĻĻāĻŋ persistent āĻŦāĻž progressive āĻšā§Ÿ, Neurologist assessment āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

āĻĒā§āϰāĻ¸ā§āϰāĻžāĻŦ āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖ āĻŦāĻ¨ā§āϧ āĻšā§Ÿā§‡ āϝāĻžāĻ“ā§ŸāĻž, āϤ⧀āĻŦā§āϰ āĻĒ⧇āϟāĻŦā§āϝāĻĨāĻž, bowel obstruction-āĻāϰ āϞāĻ•ā§āώāĻŖ, āĻ…āĻĨāĻŦāĻž āύāϤ⧁āύ neurological weakness āĻĻ⧇āĻ–āĻž āĻĻāĻŋāϞ⧇ āϜāϰ⧁āϰāĻŋ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤


14. Prescription-Ready Diagnosis Note

āφāĻĒāύāĻŋ āϰ⧋āĻ—ā§€āϰ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ⧇ āύāĻŋāĻšā§‡āϰāĻ­āĻžāĻŦ⧇ āϞāĻŋāĻ–āϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤

Dx:

  1. Suspected IBS-C vs Chronic Idiopathic Constipation (CIC)
  2. Probable BPH with LUTS
  3. Possible Anxiety Disorder with Insomnia
  4. Bilateral LL Paraesthesia — ?Peripheral Neuropathy

Short Clinical Format

Dx: Suspected IBS-C/CIC + Probable BPH with LUTS + Anxiety Symptoms + Bilateral LL Paraesthesia (under evaluation).

āĻāϟāĻŋāχ āφāĻŽāĻžāϰ āĻ•āĻžāϛ⧇ āϏāĻŦāĻšā§‡ā§Ÿā§‡ āϝāĻĨāĻžāϝāĻĨ āϏāĻ‚āĻ•ā§āώāĻŋāĻĒā§āϤ working diagnosis, āĻ•āĻžāϰāĻŖ āĻāϤ⧇ āύāĻŋāĻļā§āϚāĻŋāϤ āύāĻž āĻšāĻ“ā§ŸāĻž āϰ⧋āĻ—āϗ⧁āϞ⧋āϕ⧇ confirmed diagnosis āĻšāĻŋāϏ⧇āĻŦ⧇ āĻĻ⧇āĻ–āĻžāύ⧋ āĻšāĻšā§āϛ⧇ āύāĻžāĨ¤

Referral Note

Referred to Gastroenterology for evaluation of chronic bowel symptoms and exclusion of organic pathology. Urology consultation advised for suspected BPH-associated LUTS. Neurology review recommended for bilateral lower-limb paraesthesia.


15. Overview / Summary

āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻĒā§āϰ⧇āϏāĻ•ā§āϰāĻŋāĻĒāĻļāύ āĻŦāĻŋāĻļā§āϞ⧇āώāĻŖ āĻ•āϰ⧇ āϤāĻŋāύāϟāĻŋ āĻŽā§‚āϞ working diagnosis āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§Ÿ:

IBS-C, Enlarged Prostate āĻāĻŦāĻ‚ Anxiety DisorderāĨ¤

āφāĻŽāĻžāϰ clinical assessment āĻāχ diagnoses-āĻāϰ āϏāĻ™ā§āϗ⧇ āϏāĻžāĻŽāĻ—ā§āϰāĻŋāĻ•āĻ­āĻžāĻŦ⧇ āϏāĻžāĻŽāĻžā§āϜāĻ¸ā§āϝāĻĒā§‚āĻ°ā§āĻŖāĨ¤

āϤāĻŦ⧇ āĻ•ā§Ÿā§‡āĻ•āϟāĻŋ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻĒāĻžāĻ°ā§āĻĨāĻ•ā§āϝ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āĻĒā§āϰāĻĨāĻŽāϤ, IBS-C āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāϤ⧇ āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§Ÿ symptom criteria āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§ŸāύāĻŋāĨ¤ āϤāĻžāχ CIC-āĻ“ differential diagnosis-āĻ āϰāĻžāĻ–āϤ⧇ āĻšāĻŦ⧇āĨ¤

āĻĻā§āĻŦāĻŋāĻ¤ā§€ā§ŸāϤ, prostate enlargement āϞ⧇āĻ–āĻž āĻĨāĻžāĻ•āϞ⧇āĻ“ BPH-related obstruction āύāĻŋāĻļā§āϚāĻŋāϤ āĻ•āϰāĻžāϰ āϜāĻ¨ā§āϝ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ urological evaluation āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

āϤ⧃āĻ¤ā§€ā§ŸāϤ, bilateral lower-limb paraesthesia āφāϞāĻžāĻĻāĻž neurological assessment āĻĻāĻžāĻŦāĻŋ āĻ•āϰ⧇āĨ¤

āϏāĻŦāĻšā§‡ā§Ÿā§‡ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ prescribing safety concern āĻšāϞ⧋ Domperidone āĻ“ Escitalopram-āĻāϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ QT-prolonging interactionāĨ¤


16. Actionable Clinical Plan

  1. Confirm history: Bowel symptoms, urinary symptoms, weight loss, rectal bleeding āĻāĻŦāĻ‚ medication history āĻŦāĻŋāĻ¸ā§āϤāĻžāϰāĻŋāϤ āύāĻŋāύāĨ¤
  2. Investigate: CBC, TSH, HbA1c, electrolytes, kidney function āĻ“ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ Colonoscopy āĻāĻŦāĻ‚ NCVāĨ¤
  3. Evaluate BPH: Urinalysis, prostate volume, PVR, IPSS āĻ“ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ PSAāĨ¤
  4. Medication reconciliation: Motigut–Nexcital interaction āϝāĻžāϚāĻžāχ āĻ•āϰ⧁āύ; current therapy āĻšāϞ⧇ ECG āĻ“ electrolyte review āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰ⧁āύāĨ¤
  5. Specialist referral: Gastroenterology, Urology āĻāĻŦāĻ‚ neurological findings āĻ…āύ⧁āϝāĻžā§Ÿā§€ NeurologyāĨ¤
  6. Review diagnosis: Investigations āĻ“ symptom criteria āĻĒā§‚āϰāĻŖ āĻšāϞ⧇ final diagnosis update āĻ•āϰ⧁āύāĨ¤

17. References — Textbooks, Guidelines & DOI

A. Standard Medical Textbooks

  1. Harrison's Principles of Internal Medicine. 22nd Edition. McGraw Hill, 2025. Relevant sections: Functional gastrointestinal disorders, constipation and genitourinary disorders.
  2. Davidson's Principles and Practice of Medicine. 24th Edition. Elsevier, 2022. Relevant sections: Gastrointestinal and genitourinary medicine.
  3. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 14th Edition. McGraw Hill, 2023. Relevant sections: Gastrointestinal pharmacology, antidepressants and autonomic pharmacology.

B. Clinical Guidelines

  1. European Association of Urology (EAU). Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms, 2026.
  2. American College of Gastroenterology (ACG). Clinical Guideline: Management of Irritable Bowel Syndrome, 2021.
  3. American Gastroenterological Association / American College of Gastroenterology. Pharmacological Management of Chronic Idiopathic Constipation, 2023.
  4. European Medicines Agency (EMA). Recommendations restricting domperidone use because of cardiac risk, 2014.
  5. UK Medicines and Healthcare products Regulatory Agency (MHRA). Citalopram and escitalopram: QT interval prolongation.

C. Peer-Reviewed Journal Articles with DOI

  1. Lacy BE, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. 2021;116(1):17–44. DOI: 10.14309/ajg.0000000000001036
  2. Chang L, et al. AGA–ACG Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. American Journal of Gastroenterology. 2023;118(6):936–954. DOI: 10.14309/ajg.0000000000002227
  3. Chang L, et al. Pharmacological Management of Chronic Idiopathic Constipation. Gastroenterology. 2023;164(7):1086–1106. DOI: 10.1053/j.gastro.2023.03.214

Final Clinical Conclusion

Doctor's Dx: IBS-C + Enlarged Prostate + Anxiety Disorder.

My Working Dx: Suspected IBS-C versus CIC + Probable BPH-associated LUTS + Possible Anxiety Disorder + Bilateral LL Paraesthesia requiring evaluation.

Overall agreement: Substantial agreement with the physician's documented working diagnoses, but insufficient evidence to independently confirm all three conditions.

Md.Rafiqul Islam Lipu

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top